233 related articles for article (PubMed ID: 4540587)
1. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
2. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
3. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
4. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
5. The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.
O'Toole C; Unsgaard B; Almgård LE; Johansson B
Br J Cancer Suppl; 1973 Aug; 1():266-75. PubMed ID: 4804285
[TBL] [Abstract][Full Text] [Related]
6. Some immunological considerations relevant to the study of human bladder cancer.
Bean MA
Cancer Res; 1977 Aug; 37(8 Pt 2):2879-84. PubMed ID: 326394
[TBL] [Abstract][Full Text] [Related]
7. Standardization of microcytotoxicity assay for cell-mediated immunity.
O'Toole C
Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
[No Abstract] [Full Text] [Related]
8. Murine bladder tumors as models for human tumor immunity.
Hellström I; Hellström KE
Natl Cancer Inst Monogr; 1972 Dec; 35():125-7. PubMed ID: 4659043
[No Abstract] [Full Text] [Related]
9. Classification of the bladder cancer patient based on in vitro measurements of the immune response.
Lange PH; Hakala TR; Fraley EE
Cancer Res; 1977 Aug; 37(8 Pt 2):2885-90. PubMed ID: 326395
[TBL] [Abstract][Full Text] [Related]
10. In vitro methods for assessment of antibody-mediated tumor immunity.
Levy NL; Amos DB; Solovieff GV; dos Reis AP
Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
[No Abstract] [Full Text] [Related]
11. Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.
O'Toole C; Perlmann P; Unsgaard B; Moberger G; Edsmyr F
Int J Cancer; 1972 Jul; 10(1):77-91. PubMed ID: 4196436
[No Abstract] [Full Text] [Related]
12. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
Bean MA; Bloom BR; Herberman RB; Old LJ; Oettgen HF; Klein G; Terry WD
Cancer Res; 1975 Oct; 35(10):2902-13. PubMed ID: 1157057
[No Abstract] [Full Text] [Related]
13. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
Takasugi M; Kinoshita K
J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
[No Abstract] [Full Text] [Related]
14. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
Pizza G; De Vinci C
J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
[No Abstract] [Full Text] [Related]
15. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
[No Abstract] [Full Text] [Related]
16. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
Surg Forum; 1975; 26():122-4. PubMed ID: 56048
[No Abstract] [Full Text] [Related]
17. The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.
Troye M; Perlmann P; Pape GR; Spiegelberg HL; Näslund I; Gidlöf A
J Immunol; 1977 Sep; 119(3):1061-7. PubMed ID: 302271
[No Abstract] [Full Text] [Related]
18. Studies on specificity of cell-mediated immunity to human tumors.
Takasugi M; Mickey MR; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
[No Abstract] [Full Text] [Related]
19. In vitro immunization to cultured human tumor cells.
Sharma B; Terasaki PI
Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
[No Abstract] [Full Text] [Related]
20. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
Todd RF; Stulting RD; Berke G
Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
